Literature DB >> 24676660

Acute Chagas disease in El Salvador 2000-2012 - need for surveillance and control.

Emi Sasagawa1, Ana Vilma Guevara de Aguilar2, Marta Alicia Hernández de Ramírez2, José Eduardo Romero Chévez3, Jun Nakagawa4, Rafael Antonio Cedillos5, Kiyoshi Kita1.   

Abstract

Several parasitological studies carried out in El Salvador between 2000-2012 showed a higher frequency of acute cases of Chagas disease than that in other Central American countries. There is an urgent need for improved Chagas disease surveillance and vector control programs in the provinces where acute Chagas disease occurs and throughout El Salvador as a whole.

Entities:  

Mesh:

Year:  2014        PMID: 24676660      PMCID: PMC4015254          DOI: 10.1590/0074-0276140416

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


The high incidence of acute Chagas disease in El Salvador has been known for several years. Previous studies have suggested that acute cases of Chagas disease are rarely observed in Latin American countries (Dias & Schofield 1999) because most cases are asymptomatic, with only 1-2% of infected individuals experiencing symptoms (Coura 2007). Even though the possibility of contracting the parasite by ingestion of contaminated fruit was recently reported in Venezuela (Alarcón de Noya et al. 2010), oral transmission of Trypanosoma cruzi has not been reported in El Salvador or other Central American countries. As fewer than five acute cases are reported annually throughout the rest of Central America, the reason for the large number of acute cases in El Salvador is unclear. In most cases, individuals exhibiting symptoms of infection, including dermatologic manifestations of chagoma or Romaña’s sign, fever and malaise or who are suspected of having acute Chagas disease are referred to a health facility. Specimens collected from these individuals are sent to the nearest laboratory for examination by either direct microscopic examination of fresh blood or by the Strout method. All positive specimens are sent to the Central Laboratory of the Ministry of Health for confirmation and all acute cases are treated with nifurtimox under the supervision of a physician. The annual number of acute cases reported between 2000-2012 in each province, is shown in Table. The data presented here are secondary data collected by health personnel rather than by researchers during a formal research study. As can be observed, 731 acute cases were detected in both children and adults over 13 years. The annual number of patients with acute Chagas disease declined from 117 in 2007 to 16 in 2012. In 2011, 50% of the cases occurred in children aged zero-nine years and 91.7% of the cases occurred in individuals younger than 20 years of age.
TABLE

Number of acute Chagas cases reported per year by province, 2000-2012

RegionProvince2000200120022003200420052006200720082009201020112012Sub-total
WesternAhuachapan3202115181014735383
Santa Ana294329219101776147138
Sonsonate622010169781121175
CentralChalatenango000003146000014
La Libertad114042110801225
MetropolitanSan Salvador61951917243260208001211
ParacentralCuscatlan010003724320123
La Paz00000200520009
San Vicente00101000100003
Cabanas0016002222300027
EasternUsulutan000024502421020
San Miguel004001732199212187
Morazan000080010200011
La Union00002101100005

Total45293523541101161178957162416731

source: Department of Parasitology, Central Laboratory of the Ministry of Health in El Salvador.

source: Department of Parasitology, Central Laboratory of the Ministry of Health in El Salvador. Several factors may have contributed to the effective detection of acute Chagas disease cases, including (i) improved health facility access, permitted by small territories with a high density of medical facilities, (ii) the presence of trained health personnel who can recognise the diagnostic indicators of acute cases (Romaña’s signs and chagoma) and (iii) the presence of health promoters, who are each assigned 200 families and are required to make routine house visits to implement public health activities at least once a month. Although these favourable conditions allow for the detection of acute cases, the factors responsible for the high number of acute cases has not been determined. It is well known that successful vector control interventions have led to a reduced seroprevalence, followed by a decline in the incidence of acute infection (Dias et al. 2002). In contrast, a relatively high infestation rate of Triatoma dimidiata and serological prevalence for T. cruzi in El Salvador compared to that in neighbouring countries may be associated with a high incidence of acute infection. A 2008 entomological study of communities where insecticide spraying had not been performed found a mean T. dimidiata infestation rate of 23.4%, ranging from 15.2% in the Morazán province to 44.9% in San Miguel in El Salvador, to 4.3% in the Honduras (Aiga et al. 2012). In Guatemala, the infestation rate was recorded as 10.3% between 2000-2003, during which no spraying had occurred, but it decreased to 0.7% after a second cycle of spraying was performed between 2001-2005 (Hashimoto et al. 2012). Serological testing of children under 16 years of age in 2008 identified only one serologically positive case for T. cruzi (0.03%) in Honduras, compared to 30 (1.11%) in El Salvador (Aiga et al. 2012). Nevertheless, a serological study of children under six years of age found the seroprevalence in El Salvador (0.36%) between 1999-2000 (Cedillos et al. 2002) to be slightly lower than that in Guatemala (0.5%) between 2004-2005 (Hashimoto et al. 2012). However, routine house visits for active search of triatomine bugs by health promoters and health personnel of a vector-borne disease control program revealed that half of El Salvador has a high T. dimidiata dispersion index (Figure). This finding implies the need for urgent improvements to the surveillance and vector control programs are required in the provinces where acute Chagas disease occurs and throughout the rest of the country.

Dispersion index of Triatoma dimidiata by province, in 2011. Source: Department of Parasitology, Central Laboratory of the Ministry of Health in El Salvador.

Two limitations of this study were the use of secondary data and the inability to obtain data regarding the clinical manifestation and demographic characteristics of the subjects for further analysis. A third limitation was that the cases reported were only those detected by chance because most patients are asymptomatic during the acute phase and thus, these data represent only a small proportion of all acute Chagas disease cases. Further understanding of the epidemiology of Chagas disease requires assessment of the geographical distribution of T. dimidiata and its infestation rate. This study was performed by analysing the existing secondary data without personal information. Although this study was not presented before the ethics review board, we believe that those data will contribute to the improvement of Chagas disease control activities in El Salvador and Central American countries.
  6 in total

1.  The evolution of Chagas disease (American trypanosomiasis) control after 90 years since Carlos Chagas discovery.

Authors:  J Dias; C Schofield
Journal:  Mem Inst Oswaldo Cruz       Date:  1999       Impact factor: 2.743

2.  Chagas disease: assessing the existence of a threshold for bug infestation rate.

Authors:  Hirotsugu Aiga; Emi Sasagawa; Ken Hashimoto; Jiro Nakamura; Concepción Zúniga; José Eduardo Romero Chévez; Hector Manuel Ramos Hernández; Jun Nakagawa; Yuichiro Tabaru
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

3.  Vector control intervention towards interruption of transmission of Chagas disease by Rhodnius prolixus, main vector in Guatemala.

Authors:  Ken Hashimoto; Hugo Alvarez; Jun Nakagawa; Jaime Juarez; Carlota Monroy; Celia Cordón-Rosales; Enrique Gil
Journal:  Mem Inst Oswaldo Cruz       Date:  2012-11       Impact factor: 2.743

4.  Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela.

Authors:  Belkisyolé Alarcón de Noya; Zoraida Díaz-Bello; Cecilia Colmenares; Raiza Ruiz-Guevara; Luciano Mauriello; Reinaldo Zavala-Jaspe; José Antonio Suarez; Teresa Abate; Laura Naranjo; Manuel Paiva; Lavinia Rivas; Julio Castro; Juan Márques; Iván Mendoza; Harry Acquatella; Jaime Torres; Oscar Noya
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

5.  Chagas disease: what is known and what is needed--a background article.

Authors:  José Rodrigues Coura
Journal:  Mem Inst Oswaldo Cruz       Date:  2007-10-30       Impact factor: 2.743

Review 6.  The impact of Chagas disease control in Latin America: a review.

Authors:  J C P Dias; A C Silveira; C J Schofield
Journal:  Mem Inst Oswaldo Cruz       Date:  2002-07       Impact factor: 2.743

  6 in total
  8 in total

1.  Prevalence of Chagas Disease in the Latin American-born Population of Los Angeles.

Authors:  Sheba K Meymandi; Colin J Forsyth; Jonathan Soverow; Salvador Hernandez; Daniel Sanchez; Susan P Montgomery; Mahmoud Traina
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

2.  Implementing a vector surveillance-response system for chagas disease control: a 4-year field trial in Nicaragua.

Authors:  Kota Yoshioka; Doribel Tercero; Byron Pérez; Jiro Nakamura; Lenin Pérez
Journal:  Infect Dis Poverty       Date:  2017-03-06       Impact factor: 4.520

3.  Prevalence of Chagas Disease in a U.S. Population of Latin American Immigrants with Conduction Abnormalities on Electrocardiogram.

Authors:  Mahmoud I Traina; Salvador Hernandez; Daniel R Sanchez; Jalal Dufani; Mohsin Salih; Adieb M Abuhamidah; Wilman Olmedo; Jason S Bradfield; Colin J Forsyth; Sheba K Meymandi
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

Review 4.  Epidemiologic, Clinical and Immunological Consequences of Co-Infections during Canine Leishmaniosis.

Authors:  Erin A Beasley; Danielle Pessôa-Pereira; Breanna M Scorza; Christine A Petersen
Journal:  Animals (Basel)       Date:  2021-11-10       Impact factor: 2.752

5.  Re-emerging threat of Trypanosoma cruzi vector transmission in El Salvador, update from 2018 to 2020.

Authors:  Marvin Stanley Rodríguez; Yuko Nitahara; Michelle Cornejo; Kevin Siliezar; Rafael Grande; Ana González; Kotaro Tasaki; Yu Nakagama; Yu Michimuko; Yoko Onizuka; Junko Nakajima-Shimada; José Eduardo Romero; José Ricardo Palacios; Carmen Elena Arias; William Mejía; Yasutoshi Kido; Ricardo Cardona Alvarenga
Journal:  Infect Dis Poverty       Date:  2022-08-09       Impact factor: 10.485

6.  Elevated Pediatric Chagas Disease Burden Complicated by Concomitant Intestinal Parasites and Malnutrition in El Salvador.

Authors:  Melissa S Nolan; Kristy O Murray; Rojelio Mejia; Peter J Hotez; Maria Jose Villar Mondragon; Stanley Rodriguez; Jose Ricardo Palacios; William Ernesto Murcia Contreras; M Katie Lynn; Myriam E Torres; Maria Carlota Monroy Escobar
Journal:  Trop Med Infect Dis       Date:  2021-05-07

7.  Certifying achievement in the control of Chagas disease native vectors: what is a viable scenario?

Authors:  Ken Hashimoto; Kota Yoshioka
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-09       Impact factor: 2.743

8.  Implementation science: Epidemiology and feeding profiles of the Chagas vector Triatoma dimidiata prior to Ecohealth intervention for three locations in Central America.

Authors:  Raquel Asunción Lima-Cordón; Lori Stevens; Elizabeth Solórzano Ortíz; Gabriela Anaité Rodas; Salvador Castellanos; Antonieta Rodas; Vianney Abrego; Concepción Zúniga Valeriano; María Carlota Monroy
Journal:  PLoS Negl Trop Dis       Date:  2018-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.